CN Stock MarketDetailed Quotes

688513 Chengdu Easton Biopharmaceuticals

Watchlist
  • 36.19
  • +0.06+0.17%
Market Closed Nov 8 15:00 CST
6.39BMarket Cap25.56P/E (TTM)

Chengdu Easton Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chengdu Easton Biopharmaceuticals Q3 2024 Earnings Date

Currency：CNYOct 25, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
370.42M
--
+25.81%
Net Income
--
70.53M
--
+13.40%
Analyst Rating
Strong Buy

Nov 10, 2024

Chengdu Easton Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.729B--
--2024/FY-- / 1.393B--
--2023/FY1.117B / 1.197B--
--2022/FY1.171B / 1.173B--
Mar 29, 20222021/FY1.023B / 1.090B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.729B--
--2024/FY-- / 1.393B--
--2023/FY1.117B / 1.197B--
--2022/FY1.171B / 1.173B--
Mar 29, 20222021/FY1.023B / 1.090B--

Unlock Free Earnings Estimates

Chengdu Easton Biopharmaceuticals Earnings Reports

  • Yuandong Biology: Report for the third quarter of 2024

    Oct 25 00:00

  • Chengdu Easton Biopharmaceuticals: Half-year report for the year 2024.

    Aug 20 00:00

  • Chengdu Easton Biopharmaceuticals: Summary of Half-Year Report in 2024.

    Aug 20 00:00

  • Yuandong Biology: 2023 Annual Report Summary

    Apr 23 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 10, 2024

    Strong Buy

    • Strong Buy

      61.54%

    • Buy

      38.46%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data